Rehabilitation After Ileo-anal Pouch Surgery (RAP)

April 11, 2023 updated by: Angela Khera, St Vincent's Hospital Melbourne

Behavioural Treatment Following Ileo-Anal Pouch Formation:

Multi-centre, assessor-blinded, randomised controlled trial comparing physiotherapist-led behavioural intervention (including pelvic floor muscle training) to standard care, in the management of post-operative ileo-anal pouch patients.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Victoria
      • Fitzroy, Victoria, Australia, 3065
        • Recruiting
        • St Vincent's Hospital
      • Prahran, Victoria, Australia, 3181
        • Not yet recruiting
        • Alfred Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Proven (documented) history of Ulcerative Colitis or Familial Adenomatous Polyposis
  • Proctocolectomy and awaiting ileo-anal pouch formation or have had ileo-anal pouch created and are waiting for stoma reversal or have had stoma reversal within the last 60 days

Exclusion Criteria:

  • Primary sclerosing cholangitis
  • Significant medical or psychiatric comorbidity that in the opinion of the investigators would interfere with bowel function or adherence to the protocol
  • Clinically significant narcotic or substance abuse that in the opinion of the investigators would interfere with bowel function or adherence to the protocol
  • Recognised eating disorder
  • Non- English speaking or illiterate
  • Pregnancy
  • Current participant in another trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Intervention arm
Pelvic floor and bowel behavioural training programme provided by physiotherapists over 2- 6 sessions within the 6 months following ileostomy closure for patients with an ileo-anal pouch
Physiotherapist-led pelvic floor muscle and bowel behavioural training
Placebo Comparator: Standard arm
Standard post-operative nursing and medical care provided in hospital clinic
Standard medical and nursing care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Colo Rectal Functional Outcome Score (COREFO)
Time Frame: 6 and 12 months following ileostomy reversal
Between group comparison of outcome score - total and each of 5 domains
6 and 12 months following ileostomy reversal

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pouch Dysfunction score
Time Frame: 1,3,6 and 12 months following ileostomy closure
Comparison of scores between groups
1,3,6 and 12 months following ileostomy closure
Quality of Life Short-Form 36 (SF-36)
Time Frame: Baseline, 3,6 and 12 months following ileostomy closure
Quality of life SF-36 compared between groups - mental health domain, physical health domain and total score
Baseline, 3,6 and 12 months following ileostomy closure
Quality of Life EQ-5D
Time Frame: Baseline,3,6 and 12 months following ileostomy closure
Scores from the EQ-5D will be compared between groups and quality adjusted life years (QALY) will be derived from EQ-5D.
Baseline,3,6 and 12 months following ileostomy closure
Inflammatory Bowel Disease Questionnaire (IBDQ)
Time Frame: Baseline,3,6 and 12 months following ileostomy closure
Disease specific quality of life score comparing groups
Baseline,3,6 and 12 months following ileostomy closure
Hospital Anxiety and Depression Scale (HADs)
Time Frame: Baseline,3,6 and 12 months following ileostomy closure
Psychological well being scores for anxiety and depression comparing groups
Baseline,3,6 and 12 months following ileostomy closure
Brief Illness Perception Questionnaire
Time Frame: Baseline,3,6 and 12 months following ileostomy closure
Between group comparison of cognitive and emotional perceptions of illness
Baseline,3,6 and 12 months following ileostomy closure
Brief Cope
Time Frame: Baseline,3,6 and 12 months following ileostomy closure
Between group comparison of coping styles and ability to cope with stress
Baseline,3,6 and 12 months following ileostomy closure
New General Self-Efficacy Scale
Time Frame: Baseline,3,6 and 12 months following ileostomy closure
Between group comparison of confidence in ability to perform tasks and achieve goals
Baseline,3,6 and 12 months following ileostomy closure

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Global Impression of Improvement and Satisfaction
Time Frame: 3,6 and 12 months following ileostomy closure
Between group comparison of patient rating of improvement and satisfaction on 7-point Likert Scales
3,6 and 12 months following ileostomy closure
Adherence
Time Frame: 1,2,3,4,5 and 6 months following ileostomy closure
Patient rating of their level of adherence to the training programme
1,2,3,4,5 and 6 months following ileostomy closure
Pelvic floor muscle function
Time Frame: Baseline and 6 months following ileostomy closure
Transperineal measurements of displacement of puborectalis and change in anorectal angle with pelvic floor muscle contraction and with simulated defaecation
Baseline and 6 months following ileostomy closure
Cost to the healthcare system
Time Frame: Baseline, 6 and 12 months following ileostomy closure
Compare health care utilisation between groups
Baseline, 6 and 12 months following ileostomy closure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2017

Primary Completion (Anticipated)

June 30, 2024

Study Completion (Anticipated)

December 31, 2024

Study Registration Dates

First Submitted

April 20, 2017

First Submitted That Met QC Criteria

May 8, 2017

First Posted (Actual)

May 11, 2017

Study Record Updates

Last Update Posted (Actual)

April 12, 2023

Last Update Submitted That Met QC Criteria

April 11, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • HREC/16/SVHM/214

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Therapy Modalities

Clinical Trials on Pelvic floor and bowel behavioural training

3
Subscribe